Form 8-K - Current report:
SEC Accession No. 0001104659-23-001400
Filing Date
2023-01-05
Accepted
2023-01-05 16:05:35
Documents
15
Period of Report
2023-01-04
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm231530d1_8k.htm   iXBRL 8-K 27751
2 EXHIBIT 3.1 tm231530d1_ex3-1.htm EX-3.1 6248
3 EXHIBIT 99.1 tm231530d1_ex99-1.htm EX-99.1 12023
7 GRAPHIC tm231530d1_ex99-1img001.jpg GRAPHIC 3486
  Complete submission text file 0001104659-23-001400.txt   234450

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aytu-20230104.xsd EX-101.SCH 3030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20230104_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20230104_pre.xml EX-101.PRE 22593
9 EXTRACTED XBRL INSTANCE DOCUMENT tm231530d1_8k_htm.xml XML 3720
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 23511274
SIC: 2834 Pharmaceutical Preparations